Related Experiment Video
Updated: Jan 29, 2026
Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
Cancer immunotherapy: breaking the barriers to harvest the crop
1Sidney Kimmel Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. dmpardol@jhmi.edu
Abstract:
Successful translation of modern molecular immunology into effective cancer immunotherapy is threatened by regulatory barriers and challenges to the development of novel agents and combinatorial strategies through effective public-private partnerships. For its promise to be fully realized, both the National Cancer Institute and Food and Drug Administration must take active steps to help academic investigators and companies jointly navigate the pathways from laboratory to clinic.
Insights
Regulatory hurdles and development challenges impede translating molecular immunology into effective cancer immunotherapy. Public-private partnerships and proactive guidance from the National Cancer Institute and Food and Drug Administration are crucial for clinical advancement.
Area of Science:
- Oncology
- Immunology
- Regulatory Science
Background:
- Modern molecular immunology offers significant promise for cancer immunotherapy.
- Translating these advancements into effective clinical treatments faces substantial obstacles.
Purpose of the Study:
- To identify key barriers hindering the clinical translation of molecular immunology for cancer immunotherapy.
- To propose necessary actions for regulatory bodies and partnerships to facilitate drug development.
Main Methods:
- Analysis of regulatory pathways and challenges in cancer immunotherapy development.
- Review of existing public-private partnership models.
Main Results:
- Regulatory barriers significantly impede the development of novel agents and combinatorial strategies.
- Lack of effective public-private partnerships exacerbates these challenges.
Conclusions:
- Proactive engagement from the National Cancer Institute and Food and Drug Administration is essential.
- Streamlining pathways for academic and industry collaboration is critical for advancing cancer immunotherapy.
Related Concept Videos
05:13Rapid Detection of Helicobacter pylori Virulence and Typing Using Quantum Dot Labeling Technology
04:56Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
06:40Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
07:43Mouse Models Of Helicobacter Infection And Gastric Pathologies